Comments by "R1GAMBLER" (@R1GAMBLER) on "Moderna vaccine shows 90% efficacy" video.
-
1
-
Two Moderna board members served on the FDA.
There core funding partner pre covid was CEPI. Who's chief US strategist is married to the FDA chair. They are billionares now.
https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/
https://www.sec.gov/Archives/edgar/data/1682852/000168285219000013/moderna10-ka12312018.htm
Dr. Nabel was previously a member of Moderna’s Board of Directors from December 2015 to July 2020. She resigned from the Moderna Board in July 2020 to alleviate any potential concern about the conduct or the outcome of the COVID-19 vaccine trial when Brigham and Women’s Hospital was identified by NIH as one of the clinical sites for the Phase 3 trial. Through February 2021, she was President of Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, a position she held from 2010.
https://www.nasdaq.com/press-release/dr.-elizabeth-nabel-rejoins-modernas-board-of-directors-2021-03-10
Two Moderna board members served on the FDA.
There core funding partner pre covid was CEPI. Who's chief US strategist is married to the FDA chair. They are billionares now.
https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/
https://www.sec.gov/Archives/edgar/data/1682852/000168285219000013/moderna10-ka12312018.htm
Dr. Nabel was previously a member of Moderna’s Board of Directors from December 2015 to July 2020. She resigned from the Moderna Board in July 2020 to alleviate any potential concern about the conduct or the outcome of the COVID-19 vaccine trial when Brigham and Women’s Hospital was identified by NIH as one of the clinical sites for the Phase 3 trial. Through February 2021, she was President of Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, a position she held from 2010.
https://www.nasdaq.com/press-release/dr.-elizabeth-nabel-rejoins-modernas-board-of-directors-2021-03-10
CEPI CEO Dr. Hatchet. worked for Bush and Obamas NSC. Nicole Lauri whos married to FDA chair served 8 years Obama HHS.
She served an 8-year term as Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In that role she led the HHS response to numerous public health emergencies, ranging from infectious disease to natural and man-made disasters and is responsible for many innovations in emergency preparedness and response. She also chaired the Public Health Emergency Medical Countermeasures Enterprise, a government-wide organization ultimately responsible for the development of medical countermeasures, including vaccines against pandemics and emerging threats.
https://healthpolicy.usc.edu/author/nicole-lurie/
Previously, Dr. Hatchett served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama.
https://cepi.net/about/whoweare/
9 new vaccine billionaires.
Per CNN, the 9 new billionaires include CEOs and investors from Moderna, BioNTech, and China’s CanSino Biologics. Perhaps the most unexpected change in financial situations comes from the CEO of Moderna, Stéphane Bance, and the company’s early investors. Prior to its mRNA COVID-19 vaccine, Moderna had never received FDA approval or authorization for any of its drugs. Around the time the Moderna COVID-19 vaccine was approved for emergency use, MarketWatch reported that Moderna “that Moderna “has seen its market capitalization increase to about $54.3 billion in recent trading from just $6.6 billion at the end of 2019, according to FactSet data. In comparison, Pfizer’s market cap was $211.1 billion.”
https://edition.cnn.com/2021/05/21/business/covid-vaccine-billionaires/index.html
CEPI started by Bill and Melinda Gates...
“I look forward to helping CEPI build on the advances that have made in response to COVID-19 to transform the world’s ability to prepare and respond to epidemic and pandemic infectious diseases, and ultimately create a future in which these pathogens no longer pose an existential threat to humanity. We know that no one is safe in a pandemic. Part of CEPI’s job is to be sure no one is left behind, no matter where they live."
Dr Nicole Lurie
US Director and Strategic Advisor to the CEO
Stephen Berenson, has served as a member of our board of directors since October 2017. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan.
Lorence Kim joined TRV as a venture partner in 2020. He was previously the Chief Financial Officer of Moderna, guiding $4.4 billion of capital raising to support the company’s platform efforts in mRNA medicines and the discovery and development of a pipeline of 20+ candidates across infectious disease, oncology, rare disease and autoimmune disease. Prior to Moderna, Lorence spent 14 years at Goldman Sachs, where his last role was the co-head of the US biotech banking practice. Lorence previously served on the board of directors of Seres Therapeutics. Lorence lives with his wife and three children in New York City.
https://www.thirdrockventures.com/people/lorence-kim
Juan Andres CTO
Moderna, Inc. (NASDAQ:MRNA) insider Juan Andres sold 5,000 shares of Moderna stock in a transaction on Wednesday, June 23rd. The shares were sold at an average price of $219.65, for a total value of $1,098,250.00.
https://www.sec.gov/Archives/edgar/data/1682852/000112760221020697/xslF345X03/form4.xml
Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. (Nasdaq: AZN) and Merck, Inc. (Nasdaq: MRK), as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been named a top biopharmaceutical employer by Science for the past five years.
Moncef Mohamed Slaoui[1] is a Moroccan-born Belgian-American researcher who served as the Head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021
To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna, which had been developing a vaccine for the coronavirus.Slaoui faced criticism, particularly from Senator Elizabeth Warren, for continuing to have Moderna stock options worth over $10 million.[33][34] On May 18, 2020, Slaoui resigned from the board of manufacturing firm Lonza, which Moderna had partnered with to develop a coronavirus vaccine.[35] On May 19, after initially denying a conflict of interest, Slaoui divested his Moderna stock and donated the value it had gained from May 14 onwards to cancer research.
Slaoui resigned from OPWASP on January 12, 2021.
On March 24, 2021, Slaoui was fired as Chairman of the board of directors of Galvani Bioelectronics over historical sexual harassment allegations.
1
-
Two Moderna board members served on the FDA.
There core funding partner pre covid was CEPI. Who's chief US strategist is married to the FDA chair. They are billionares now.
https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/
https://www.sec.gov/Archives/edgar/data/1682852/000168285219000013/moderna10-ka12312018.htm
Dr. Nabel was previously a member of Moderna’s Board of Directors from December 2015 to July 2020. She resigned from the Moderna Board in July 2020 to alleviate any potential concern about the conduct or the outcome of the COVID-19 vaccine trial when Brigham and Women’s Hospital was identified by NIH as one of the clinical sites for the Phase 3 trial. Through February 2021, she was President of Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, a position she held from 2010.
https://www.nasdaq.com/press-release/dr.-elizabeth-nabel-rejoins-modernas-board-of-directors-2021-03-10
Two Moderna board members served on the FDA.
There core funding partner pre covid was CEPI. Who's chief US strategist is married to the FDA chair. They are billionares now.
https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/
https://www.sec.gov/Archives/edgar/data/1682852/000168285219000013/moderna10-ka12312018.htm
Dr. Nabel was previously a member of Moderna’s Board of Directors from December 2015 to July 2020. She resigned from the Moderna Board in July 2020 to alleviate any potential concern about the conduct or the outcome of the COVID-19 vaccine trial when Brigham and Women’s Hospital was identified by NIH as one of the clinical sites for the Phase 3 trial. Through February 2021, she was President of Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, a position she held from 2010.
https://www.nasdaq.com/press-release/dr.-elizabeth-nabel-rejoins-modernas-board-of-directors-2021-03-10
CEPI CEO Dr. Hatchet. worked for Bush and Obamas NSC. Nicole Lauri whos married to FDA chair served 8 years Obama HHS.
She served an 8-year term as Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. In that role she led the HHS response to numerous public health emergencies, ranging from infectious disease to natural and man-made disasters and is responsible for many innovations in emergency preparedness and response. She also chaired the Public Health Emergency Medical Countermeasures Enterprise, a government-wide organization ultimately responsible for the development of medical countermeasures, including vaccines against pandemics and emerging threats.
https://healthpolicy.usc.edu/author/nicole-lurie/
Previously, Dr. Hatchett served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama.
https://cepi.net/about/whoweare/
9 new vaccine billionaires.
Per CNN, the 9 new billionaires include CEOs and investors from Moderna, BioNTech, and China’s CanSino Biologics. Perhaps the most unexpected change in financial situations comes from the CEO of Moderna, Stéphane Bance, and the company’s early investors. Prior to its mRNA COVID-19 vaccine, Moderna had never received FDA approval or authorization for any of its drugs. Around the time the Moderna COVID-19 vaccine was approved for emergency use, MarketWatch reported that Moderna “that Moderna “has seen its market capitalization increase to about $54.3 billion in recent trading from just $6.6 billion at the end of 2019, according to FactSet data. In comparison, Pfizer’s market cap was $211.1 billion.”
https://edition.cnn.com/2021/05/21/business/covid-vaccine-billionaires/index.html
CEPI started by Bill and Melinda Gates...
“I look forward to helping CEPI build on the advances that have made in response to COVID-19 to transform the world’s ability to prepare and respond to epidemic and pandemic infectious diseases, and ultimately create a future in which these pathogens no longer pose an existential threat to humanity. We know that no one is safe in a pandemic. Part of CEPI’s job is to be sure no one is left behind, no matter where they live."
Dr Nicole Lurie
US Director and Strategic Advisor to the CEO
Stephen Berenson, has served as a member of our board of directors since October 2017. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan.
Lorence Kim joined TRV as a venture partner in 2020. He was previously the Chief Financial Officer of Moderna, guiding $4.4 billion of capital raising to support the company’s platform efforts in mRNA medicines and the discovery and development of a pipeline of 20+ candidates across infectious disease, oncology, rare disease and autoimmune disease. Prior to Moderna, Lorence spent 14 years at Goldman Sachs, where his last role was the co-head of the US biotech banking practice. Lorence previously served on the board of directors of Seres Therapeutics. Lorence lives with his wife and three children in New York City.
https://www.thirdrockventures.com/people/lorence-kim
Juan Andres CTO
Moderna, Inc. (NASDAQ:MRNA) insider Juan Andres sold 5,000 shares of Moderna stock in a transaction on Wednesday, June 23rd. The shares were sold at an average price of $219.65, for a total value of $1,098,250.00.
https://www.sec.gov/Archives/edgar/data/1682852/000112760221020697/xslF345X03/form4.xml
Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. (Nasdaq: AZN) and Merck, Inc. (Nasdaq: MRK), as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been named a top biopharmaceutical employer by Science for the past five years.
Moncef Mohamed Slaoui[1] is a Moroccan-born Belgian-American researcher who served as the Head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021
To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna, which had been developing a vaccine for the coronavirus.Slaoui faced criticism, particularly from Senator Elizabeth Warren, for continuing to have Moderna stock options worth over $10 million.[33][34] On May 18, 2020, Slaoui resigned from the board of manufacturing firm Lonza, which Moderna had partnered with to develop a coronavirus vaccine.[35] On May 19, after initially denying a conflict of interest, Slaoui divested his Moderna stock and donated the value it had gained from May 14 onwards to cancer research.
Slaoui resigned from OPWASP on January 12, 2021.
On March 24, 2021, Slaoui was fired as Chairman of the board of directors of Galvani Bioelectronics over historical sexual harassment allegations.
1
-
1